m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer.
Zi-Hao FengYan-Ping LiangJun-Jie CenHao-Hua YaoHai-Shan LinJia-Ying LiHui LiangZhu WangQiong DengJia-Zheng CaoYong HuangJin-Huan WeiJun-Hang LuoWei ChenZhen-Hua ChenPublished in: Journal of translational medicine (2022)
An m6A-immune-related lncRNA risk model was established in this study, which can be applied to predict prognosis, immune landscape and chemotherapeutic response in bladder cancer.